About Immuneering Corp. 
Immuneering Corp.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 18 Schemes (24.67%)
Foreign Institutions
Held by 45 Foreign Institutions (10.26%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Mar 2026)
Net Profit:
-13 Million
Pharmaceuticals & Biotechnology
USD 321 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.79
-25.64%
1.47






